More Investing
View Older Stories View Newer Stories-
Google launches three new Gemini AI models, expands push into cybersecurity
-
SpaceXAI brings Grok to Microsoft Outlook
-
Airbus stock jumps on new mid-term outlook and buyback plan
-
Chinese Open LLMs are no threat to memory demand, BofA says
-
Klarna shares surge 9% on Apple device leasing partnership
-
Nvidia hits the gas: Next-gen "Vera Rubin" AI chips enter full production
-
Michigan reports 6,571 cyclosporiasis cases in ongoing outbreak
-
Jefferies downgrades Datadog after 94% YTD rally
-
Moonshot AI eyes $50 billion valuation, Hong Kong IPO after Kimi K3 breakthrough
-
Intel plans layoffs in data center division - Business Insider
-
Macquarie sees prime SpaceX entry point, reaffirms $250 target on SPCX
-
UBS recommends adding gold exposure on pullbacks at this price
-
Emirates refusing to take delivery of first 10 Boeing 777X jets
-
Tesla expands robotaxi service to Orlando and Tampa
-
Goldman is confident these 2 security stocks can grow their valuations
-
This major stocks offers "one of the most attractive risk/reward profiles": Mizuho
-
US tariffs on Canada are a "targeted measure," says Greer
-
BTIG downgrades TripAdvisor on AI risks, sees limited catalysts after TheFork sale
-
JPMorgan sees clean energy pullback as buying opportunity ahead of earnings
-
Bernstein upgrades Five Below to Outperform, sees 22% upside on stronger outlook
-
Morgan Stanley says software selloff has gone too far, names 8 winners
-
China cuts Iranian oil purchases by 40%, Bessentsays
-
Bessent says U.S. watermarks found on Chinese AI models
-
Utz Brands taken private in $2.9 billion deal with Germany’s Intersnack
-
Raymond James upgrades Ralph Lauren on stronger growth outlook ahead of earnings
-
Citi's Chew says U.S. stock positioning unwind may not be over
-
Novo Nordisk sues Eli Lilly in high-stakes GLP-1 advertising feud
-
Charles Schwab shares slide despite record Q2 revenue, EPS beat
-
Northrop Grumman beats Q2 estimates, raises guidance
-
Novo Nordisk sues Eli Lilly over weight-loss drug ads
-
Novartis CEO says will stay with drugmaker for next growth phase
-
Halliburton stock slides despite earnings and revenue beating expectations
-
Adobe, Salesforce and Intuit fall as Morgan Stanley begins cautious coverage
-
D.R. Horton up in premarket after Q3 earnings beat despite weak outlook
-
IEA monitoring oil markets amid Middle East supply concerns
-
Shohin Airlines orders four Airbus A320neo family aircraft
-
3M lifts annual guidance after Q2 results top estimates; shares jump
-
GM beats second-quarter estimates, raises full-year guidance
-
Boeing pushes U.S. to look into EU loan to Airbus
-
Philippine Airlines signs deal for nine more Airbus A350-1000 aircraft
-
Danaher shares tumble despite earnings beat
-
Abu Dhabi invests $6.2bn in offshore gas field development
-
Trump to impose new tariffs on dozens of countries this week, FT reports
-
Chip stocks extend global rebound following last week's rout
-
US imposes 50% tariffs on wide range of Canadian products
-
Raytheon wins $1.8B Navy radar contract modification
-
SpaceX sets date for maiden earnings report: Why August 4 is make-or-break
-
Darline Graham enters South Carolina Senate race
-
US gas prices climb above $4 a gallon as oil surges amid Iran tensions
-
Judge temporarily blocks Paramount-Skydance’s $110 bln Warner Bros Discovery deal
